MetrionAIIntelligence

Sign in Register

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading market dashboard

My Watchlist

Sign in to track securities

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Crescent Biopharma, Inc.

CBIO

HealthcareNASDAQUS

Sign in to save

$18.00

-$0.45 (-2.44%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

CBIO

1Y-0.45 (-2.44%)

Candles, volume, SMA 20, and SMA 50

O 18.19H 19L 17.5C 18Date Jun 5

CBIO

SMA 20 SMA 50 Vol 192.62KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates. Its pipeline includes CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics, including novel combinations. The company is headquartered in Waltham, Massachusetts.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$496.29M

Volume?192.62K

Avg Volume?275.65K

52w Range$8.72 - $27.41

Beta?1.15

Price Performance

1M

0.0%

$18.00 to $18.00

YTD

+51.8%

$11.86 to $18.00

1Y

-7.1%

$19.38 to $18.00

3Y

-90.5%

$189.00 to $18.00

5Y

-93.1%

$261.00 to $18.00

10Y

-97.9%

$847.00 to $18.00

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOJoshua T. Brumm

IndustryBiotechnology

Employees41

IPO Date2014-01-10

CurrencyUSD

Websitecrescentbiopharma.com

Related stocks

Check out other names from the same Biotechnology industry as CBIO.

Armata Pharmaceuticals, Inc.

C4 Therapeutics, Inc.

Vyome Holdings, Inc.

Heron Therapeutics, Inc.

Insight Molecular Diagnostics Inc.

Innate Pharma S.A.

Sangamo Therapeutics, Inc.

Tonix Pharmaceuticals Holding Corp.